Cytokine storm syndrome
[대역어] 사이토 카인 폭풍 증후군
[용어속성] Disease
[용어속성] Disease
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome
Review article
Published on
Journal: Transfusion and apheresis science : official journ
[Category] SARS, 바이오마커, 임상, 치료제,
Journal: Transfusion and apheresis science : official journ
[Category] SARS, 바이오마커, 임상, 치료제,
[키워드] member 13
a disintegrin and metalloproteinase with a thrombospondin type 1 motif
acute respiratory syndrome
ADAMTS-13a disintegrin and metalloproteinase with a thrombospondin type 1 motif
American Society for Apheresis
approach
ARDSacute respiratory syndrome
article
ASFAAmerican Society for Apheresis
available data
benefit
C-reactive protein
Case series
Case-control
CCPCOVID-19 convalescent plasma
Clinical outcome
Coagulopathy
conducted
Controlled clinical trial
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 convalescent plasma
COVID-19coronavirus disease 2019
criteria
Critically ill patient
CRPC-reactive protein
CSS
CSScytokine storm syndrome
Cytokine storm syndrome
Cytokines
D-dimer
Effects
Evidence
excessive immune response
feasibility
ferritin
FFPfresh frozen plasma
fibrinogen level
fresh frozen plasma
hypercoagulable
Hyperinflammatory
ICUIntensive Care Unit
identify
IFNinterferon
ILInterleukin
immunomodulatory effect
improvement
Inflammatory factor
intensive care unit
interferon
interleukin
interleukin-6
Intervention
Length of stay
LOSlength of stay
Lymphocyte count
macrophage activation syndrome
management
MASmacrophage activation syndrome
MODSmultiple organ dysfunction syndrome
Mortality
multiple organ dysfunction syndrome
offer
offset
PaO2:FiO2pressure of arterial oxygen to fractional inspired oxygen concentration
pathologic
Patient
patients
patients with COVID-19
peer-reviewed
potential clinical benefits
pressure of arterial oxygen to fractional inspired oxygen concentration
prevent disease progression
Randomized
Randomized controlled trial
RCTrandomized controlled trial
reduce
reduce mortality
resulting
risk
role
Safe
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
secondary hemophagocytic lymphohistiocytosis
selected
Sequential Organ Failure Assessment
severe acute respiratory syndrome coronavirus 2
sHLHsecondary hemophagocytic lymphohistiocytosis
SOFASequential Organ Failure Assessment
TAMOFthrombocytopenia-associated multiple organ failure
Therapeutic plasma exchange
thrombocytopenia-associated multiple organ failure
TNFTumor Necrosis Factor
TPE
TPEtherapeutic plasma exchange
treat
Treatment
tumor necrosis factor
while
with COVID-19
[DOI] 10.1016/j.transci.2022.103433 [Article Type] Review article
[DOI] 10.1016/j.transci.2022.103433 [Article Type] Review article
Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
토실리주맙 치료를 받는 COVID-19 환자의 종합적인 사이토카인 프로파일링
Article
Published on
Journal: International Journal of Molecular Sciences
[Category] COVID19(2023년), SARS, 진단,
Journal: International Journal of Molecular Sciences
[Category] COVID19(2023년), SARS, 진단,
[키워드] addition
Administered
administration
Admission
analyzed
anti-cytokine
anti-cytokine therapy
Blood
changes
characterized
circulating cytokine
Clinical endpoints
Cluster
Comprehensive
Concentration
Coronavirus disease 2019
correlated
COVID-19
criteria
CSS
cytokine
cytokine profile
Cytokine storm
Cytokine storm syndrome
Cytokines
defined
demonstrated
disease severity
Follow-up
follow-up period
G-CSF
group
hospitalized patient
IL-10
IL-1ra
IL-6
immune activation
in both group
increased mortality
indication
Inflammation
interleukin
Laboratory
laboratory parameter
multiple cytokines
multiplex
parameter
pathophysiological mechanism
Patient
performed
plasma
Profiling
Prognosis
separated
Severe case
the patient
to define
Tocilizumab
tocilizumab therapy
tocilizumab.
treatment with tocilizumab
viral spread
with COVID-19
[DOI] 10.3390/ijms23147937 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23147937 PMC 바로가기 [Article Type] Article
Screening Protocol and Prevalence of Venous Thromboembolic Disease in Hospitalized Patients With COVID-19
COVID-19로 입원한 환자에서 정맥 혈전색전증의 스크리닝 프로토콜 및 유병률
Observational Study
[키워드] AUC
benefit
Cohort
Computed tomography
conducted
COVID-19
COVID-19 patient
COVID-19 patients
CSS
Cytokine storm syndrome
D-dimer
Deep vein
Deep vein thrombosis
detect
determine
diagnosing
dimer
disease
DVT
endothelial damage
evidenced
facilitate
Factor
Future
hospitalized patients
hypercoagulability
hypoxia
immobilization
induce
Inflammatory
laboratory parameter
Mortality
no difference
no differences
observational study
Older
Patient
patients with COVID-19
performed
point-of-care
positive
Prevalence
prospective observational study
pulmonary computed tomography
Pulmonary embolism
ROC Curve
SARS-CoV-2 disease
SARS-CoV2
Screening
screening strategy
Sensitivity and specificity
Society
sustained
syndrome
the cytokine storm
the patient
Thromboprophylaxis
thrombosis
Trial
Ultrasound
ultrasound.
undergo
venous thromboembolic
[DOI] 10.1002/jum.15850 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1002/jum.15850 PMC 바로가기 [Article Type] Observational Study
Immune-based therapeutic approaches in COVID-19
COVID-19의 면역 기반 치료 접근법
Review
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단,
[키워드] acute respiratory syndrome
antibodies
approach
ARDS
caused
Complication
coronavirus
Coronavirus disease 2019
Coronavirus-2
Corticosteroids
COVID-19
COVID-19 pathogenesis
COVID-19 research
Cytokine storm syndrome
eliminating
Epidemic
immune
immune system
Immunotherapy
interferon
Intravenous immunoglobulin
IVIG
measure
monoclonal antibody
not applicable
pandemic
pathogen
physical
Pneumonia
SARS
SARS-CoV-2
SARS-CoV-2.
social distancing
the Coronaviridae
the disease
therapeutic approach
therapy
Treatment
vaccination
viral disease
WHO
World Health Organization
[DOI] 10.1016/j.biopha.2022.113107 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.biopha.2022.113107 PMC 바로가기 [Article Type] Review
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
Research article
Published on
Journal: The Journal of Allergy and Clinical Immunology
[Category] COVID19(2023년), SARS, 변종, 치료법,
Journal: The Journal of Allergy and Clinical Immunology
[Category] COVID19(2023년), SARS, 변종, 치료법,
[키워드] Activation
acute respiratory syndrome
Analysis
analyzed
Anti-inflammatory therapy
apoptotic
ASC
Blood
cDNA
cell line
circulating monocyte
circulating monocytes
coding
confocal microscopy
coronavirus
COVID-19
Critically ill
cytokine
cytokine secretion
Cytokine storm syndrome
disease
dissect
driving
effective
Efficacy
Evidence
Frame
IL-1 receptor antagonist
IL-1β
in vitro
Infection
Inflammasome
inflammasomes
Inflammation
Inflammatory
inflammatory parameters
manifestation
maturation
mechanism
NLRP3
NLRP3 inflammasome
objective
ORF3a
pathway
Patient
patients with COVID-19
Phenotypes
Plasma cytokine
receptor protein
reducing mortality
regulated
respond
Result
RNA sequencing
SARS-CoV-2
SARS-CoV-2 protein
secrete
secretion
severe coronavirus disease
severe COVID-19 patient
severe pneumonia
shown
Spontaneous
transfection
Treatment
Trigger
with COVID-19
[DOI] 10.1016/j.jaci.2022.05.029 [Article Type] Research article
[DOI] 10.1016/j.jaci.2022.05.029 [Article Type] Research article
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial
Randomized Controlled Trial
[키워드] Admission
aggravate
anti-inflammatory treatment
applied
Arm
benefit
clinical benefit
Colchicine
colchicine group
colchicine treatment
components
CPAP
Cytokine storm syndrome
death
develop
dose
Efficacy
Endpoint
EudraCT
hospitalized patient
hyperinflammation
ICU admission
in both groups
intensive care
Invasive mechanical ventilation
investigator-initiated trial
mechanical ventilation
moderate
Most patient
Non-invasive
observer-blinded
occurred
outcome
outcome measure
Patient
patients with COVID-19
Pneumonia
Primary outcome
pulmonary disease
Randomized
randomized clinical trial
Randomly
receive
Severe COVID-19 pneumonia
standard care
steroid
study population
Trial
with COVID-19
[DOI] 10.1038/s41598-022-13424-6 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1038/s41598-022-13424-6 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 age-dependent immunology and clinical outcomes: implications for vaccines
Review
Published on
Journal: Journal of Developmental Origins of Health and Disease
[Category] COVID19(2023년),
Journal: Journal of Developmental Origins of Health and Disease
[Category] COVID19(2023년),
[키워드] Adaptive immunity
coronavirus
Cytokine storm syndrome
Innate immunity
multisystem inflammatory syndrome.
[DOI] 10.1017/S2040174421000398 PMC 바로가기 [Article Type] Review
[DOI] 10.1017/S2040174421000398 PMC 바로가기 [Article Type] Review
Gastrointestinal manifestations of COVID-19 in a single center in the Eastern Province of Saudi Arabia
Observational Study
Published on
Journal: Saudi journal of gastroenterology : official journ
[Category] COVID19(2023년), SARS, 임상,
Journal: Saudi journal of gastroenterology : official journ
[Category] COVID19(2023년), SARS, 임상,
[키워드] 95% CI
abdominal pain
acute respiratory distress
Altered mental status
AOR
association
conducted
COVID-19
COVID-19 infection
Cytokine storm syndrome
death
diarrhea
Gastrointestinal
gastrointestinal manifestations
GI symptom
higher risk
hospital
hospitalized COVID-19 patient
less
lower mortality
lung field
lung infiltration
manifestation
Manifestations
Middle East
Mortality
mortality rate
multiorgan failure
nausea
Novel coronavirus
outcome
Patient
patients
PCR test
positive
Prevalence
reported
retrospective
Saudi Arabia
severe COVID-19 disease
severity
Severity.
single center
Symptom
syndrome
university hospital
vomiting
[DOI] 10.4103/sjg.sjg_547_21 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.4103/sjg.sjg_547_21 PMC 바로가기 [Article Type] Observational Study
Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection
Research
[키워드] acute inflammatory response
acute respiratory distress
analyzed
ARDS
cellular
COVID-19
COVID-19 patients
Cytokine storm
Cytokine storm syndrome
dataset
differentially expressed miRNA
enriched pathway
fat cell
fold
Gene Expression
hallmark
immune
immune dysregulation
in silico analysis
independent
Infection
Inflammatory response
Inflammatory responses
intensive care
involved
mechanical ventilation
microRNA
miRNA
miRNAs
parameter
pathway enrichment
Patient
patient groups
physiological
Prognosis
qPCR
receptor protein
Regulation
resulting
SARS-COV-2 infection
Sequencing
significantly
Symptom
syndrome
transmembrane
was performed
with COVID-19
[DOI] 10.1038/s41598-022-10738-3 [Article Type] Research
[DOI] 10.1038/s41598-022-10738-3 [Article Type] Research